Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial
Angela R Branche, Satoshi Kamidani, Siham M. Mahgoub, David Joseph Diemert et al.
Journal
Vaccine
Topics
SARS-CoV-2 and COVID-19 Research
article
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial
Angela R Branche, Satoshi Kamidani, Siham M. Mahgoub, David Joseph Diemert, Lisa A. Jackson, Paul C. Roberts, John H. Beigel, Craig A. Magaret, Nadine Rouphael, Rachel M. Presti, Thomas Martin, Dean A. Follmann, Harm van Bakel, Daniel S. Graciaa, Peter B. Gilbert, Bo Zhang, Viviana Simon, Tara M Babu
article en
Abstract
No abstract available for this paper.
Publication Tag
VaccineVol. 64
Institutions
National Institutes of Health (US), Kaiser Permanente Washington Health Research Institute (US), George Washington University (US), University of Washington (US), Washington University in St. Louis (US), University of California San Diego (US), Fred Hutch Cancer Center (US), Howard University Hospital (US), HOPE Clinic (US), National Institute of Allergy and Infectious Diseases (US), Vaccinex (United States) (US), Children's Healthcare of Atlanta (US), University of Rochester (US), Icahn School of Medicine at Mount Sinai (US)